Clinical Trial Update: Evaluation of SYS6005 in Patients With Advanced Malignant Tumor [Phase 1]

View source ↗

Summary

Phase 1 study evaluating SYS6005 in adults with advanced malignant tumors, including B-cell malignancies and solid tumors. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Malignancies
• Solid Tumors

Drugs mentioned

• SYS6005

Snippet

Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. | Conditions: B-cell Malignancies, Solid Tumors | Phase 1 | Status: RECRUITING